Search Results 791-800 of 21318 for anti-TNF drugs

1. Calcium Acetate (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Eliphos; PhosLo; Phoslyra. Descriptions.

2. Ethinyl Estradiol And Ethynodiol Diacetate (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

   Participation eligibility · Subjects who received anticancer therapy or investigational drug within 28 days of first dose. · Subjects who received any approved ...

4. Calcipotriene (Topical Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Calcitrene; Dovonex; Sorilux. Descriptions.

5. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

   Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

6. Tailored Antiplatelet Therapy Following PCI - Mayo Clinic

   Clopidogrel is an anti-platelet medication approved by the U.S. Federal Drug Administration (FDA) for use in patients who undergo Percutaneous Coronary ...

7. Loteprednol And Tobramycin (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Zylet. Descriptions. Loteprednol and tobramycin ophthalmic ...

8. Cyclopentolate (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Cyclogyl; Cylate; Ocu-Pentolate. Canadian Brand Name.

9. Fighting Parkinson’s Disease and Lewy Body Dementia with Anti-Diabetic Medications to - Mayo Clinic

   Clinical Trials · Fighting Parkinson's Disease and Lewy Body Dementia with Anti-Diabetic Medications to · More about research at Mayo Clinic · Mayo Clinic Footer.

10. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...